111 related articles for article (PubMed ID: 17767067)
1. [Comparison of treatment response in primary hepatocellular carcinomas with contrast-enhanced ultrasonography and contrast-enhanced helical CT].
Zhou P; Liu XY; Li RZ; Nie WP; Liu S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):690-4. PubMed ID: 17767067
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma.
Numata K; Isozaki T; Ozawa Y; Sakaguchi T; Kiba T; Kubota T; Ito A; Sugimori K; Shirato K; Morimoto M; Tanaka K
AJR Am J Roentgenol; 2003 Jan; 180(1):143-9. PubMed ID: 12490493
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance.
Giorgio A; Ferraioli G; Tarantino L; de Stefano G; Scala V; Scarano F; Coppola C; Del Viscovo L
AJR Am J Roentgenol; 2004 Nov; 183(5):1319-26. PubMed ID: 15505297
[TBL] [Abstract][Full Text] [Related]
4. Using contrast-enhanced sonography to assess the effectiveness of transcatheter arterial embolization for hepatocellular carcinoma.
Numata K; Tanaka K; Kiba T; Saito S; Isozaki T; Hara K; Morimoto M; Sekihara H; Yonezawa H; Kubota T
AJR Am J Roentgenol; 2001 May; 176(5):1199-205. PubMed ID: 11312181
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Morimoto M; Shirato K; Sugimori K; Kokawa A; Tomita N; Saito T; Imada T; Tanaka N; Nozawa A; Numata K; Tanaka K
AJR Am J Roentgenol; 2003 Jul; 181(1):65-9. PubMed ID: 12818831
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography.
Shiozawa K; Watanabe M; Takayama R; Takahashi M; Wakui N; Iida K; Sumino Y
J Clin Ultrasound; 2010 May; 38(4):182-9. PubMed ID: 20232404
[TBL] [Abstract][Full Text] [Related]
7. Application of percutaneous ultrasound-guided treatment for ultrasonically invisible hypervascular hepatocellular carcinoma using microbubble contrast agent.
Maruyama H; Kobayashi S; Yoshizumi H; Okugawa H; Akiike T; Yukisawa S; Fukuda H; Matsutani S; Ebara M; Saisho H
Clin Radiol; 2007 Jul; 62(7):668-75. PubMed ID: 17556036
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of treatment response after chemoembolisation (TACE) in hepatocellular carcinoma using real time image fusion of contrast-enhanced ultrasound (CEUS) and computed tomography (CT)--preliminary results.
Wobser H; Wiest R; Salzberger B; Wohlgemuth WA; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2014; 57(2):191-201. PubMed ID: 24577382
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.
Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C;
J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796
[TBL] [Abstract][Full Text] [Related]
10. Sono-hepatic-arteriography (Sono-HA) in the assessment of hepatocellular carcinoma in patients undergoing transcatheter arterial chemoembolization (TACE).
Schacherer D; Girlich C; Zorger N; Wiest R; Schoelmerich J; Feuerbach S; Jung EM
Ultraschall Med; 2010 Jun; 31(3):270-5. PubMed ID: 20408118
[TBL] [Abstract][Full Text] [Related]
11. Power Doppler sonography assessment of tumor recurrence after chemoembolization therapy for hepatocellular carcinoma.
Sumi S; Yamashita Y; Mitsuzaki K; Yamamoto H; Urata J; Nishiharu T; Takahashi M
AJR Am J Roentgenol; 1999 Jan; 172(1):67-71. PubMed ID: 9888742
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome.
Cioni D; Lencioni R; Rossi S; Garbagnati F; Donati F; Crocetti L; Bartolozzi C
AJR Am J Roentgenol; 2001 Oct; 177(4):783-8. PubMed ID: 11566673
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT.
Meloni MF; Goldberg SN; Livraghi T; Calliada F; Ricci P; Rossi M; Pallavicini D; Campani R
AJR Am J Roentgenol; 2001 Aug; 177(2):375-80. PubMed ID: 11461867
[TBL] [Abstract][Full Text] [Related]
14. Depiction of viable tumor in hepatocellular carcinoma treated with transarterial chemoembolization: multiphasic helical CT with review of the previous serial CT images.
Jang KM; Choi D; Lim HK; Lim JH; Lee JY; Lee WJ; Kim SH; Lee SJ; Jeon YH; Lee J; Kim MJ; Shin SW; Park CK
Korean J Radiol; 2005; 6(3):153-60. PubMed ID: 16145290
[TBL] [Abstract][Full Text] [Related]
15. Helical CT screening for hepatocellular carcinoma in patients with cirrhosis: frequency and causes of false-positive interpretation.
Brancatelli G; Baron RL; Peterson MS; Marsh W
AJR Am J Roentgenol; 2003 Apr; 180(4):1007-14. PubMed ID: 12646446
[TBL] [Abstract][Full Text] [Related]
16. Radiologic monitoring of hepatocellular carcinoma tumor viability after transhepatic arterial chemoembolization: estimating the accuracy of contrast-enhanced cross-sectional imaging with histopathologic correlation.
Hunt SJ; Yu W; Weintraub J; Prince MR; Kothary N
J Vasc Interv Radiol; 2009 Jan; 20(1):30-8. PubMed ID: 19028117
[TBL] [Abstract][Full Text] [Related]
17. [The correlation between Doppler echography with a contrast medium and CT in the study of a hepatocarcinoma submitted to chemoembolization].
Catalano O; Cusati B; Esposito M; Trivellini V; Lobianco R; Siani A
Radiol Med; 1998 Jun; 95(6):608-13. PubMed ID: 9717543
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced sonography in the characterization of small hepatocellular carcinomas in cirrhotic patients: comparison with contrast-enhanced ultrafast magnetic resonance imaging.
Giorgio A; De Stefano G; Coppola C; Ferraioli G; Esposito V; Di Sarno A; Giorgio V; De Stefano M; Sangiovanni V; Liorre G; Del Viscovo L
Anticancer Res; 2007; 27(6C):4263-9. PubMed ID: 18214030
[TBL] [Abstract][Full Text] [Related]
19. Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging.
Hayashida M; Ito K; Fujita T; Shimizu A; Sasaki K; Tanabe M; Matsunaga N
Magn Reson Imaging; 2008 Jan; 26(1):65-71. PubMed ID: 17566685
[TBL] [Abstract][Full Text] [Related]
20. Contribution of Contrast-Enhanced Sonography With Perfluorobutane Microbubbles for Diagnosis of Recurrent Hepatocellular Carcinoma.
Shagdarsuren B; Tamai H; Shingaki N; Mori Y; Maeshima S; Nuta J; Maeda Y; Moribata K; Niwa T; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
J Ultrasound Med; 2016 Jul; 35(7):1383-91. PubMed ID: 27208196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
